Clinical & Translational Research
The primary scientific goal of the Clinical and Translational Research Program is to translate discoveries of the Center's research into clinical applications. By so doing, it will generate innovative, high impact clinical/translational research to substantially reduce the burden of cancer for the people of Hawaii and elsewhere using opportunities afforded by:
- Hawaii's multiethnic population with disparate cancer risks
- Medicinal properties of Hawaii's flora/fauna
The research aims to identify practice changing interventions including agents, devices and diagnostic tests (prognostic and predictive) that when applied help more than harm individual patients. Within the theme of Hawaii's multiethnic population with disparate cancer risks, we have narrowed our focus to cancers which give certain minorities and vulnerable populations the greatest disparate cancer burden. They are:
- Liver cancer
- Breast cancer
In this way the resources of the Clinical and Translational Research Program are applied in areas where research is naturally advantaged and have the greatest potential impact on Hawaii's population.
The foundation for the Clinical and Translational Research Program is the Center's clinical trials system which for many years has successfully provided Hawaii's community-based providers and the patients they serve with access to clinical trials. These trials provide Hawaii patients with access to the most promising research opportunities and contribute Hawaii's unique multi-ethnic population to large nationally conducted trials. Hawaii's cancer care providers remain at the cutting edge of state-of-the-science care through their participation in the research and associated continuing education activities. This assures that in most cases patients can receive best care without having to leave the islands.
Clinical and Translational Research Program
701 Ilalo Street
Honolulu, HI 96813
Telephone: (808) 356-5798
Fax: (808) 586-3009